Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 15.93%2.95B | 15.15%2.84B | 12.70%2.65B | 19.76%10.07B | 16.46%2.7B | 19.57%2.54B | 21.09%2.47B | 22.73%2.35B | 26.93%8.41B | 25.60%2.32B |
| Operating revenue | 15.93%2.95B | 15.15%2.84B | 12.70%2.65B | 19.76%10.07B | 16.46%2.7B | 19.57%2.54B | 21.09%2.47B | 22.73%2.35B | 26.93%8.41B | 25.60%2.32B |
| Cost of revenue | 12.39%1.82B | 9.95%1.77B | 10.56%1.71B | 18.13%6.45B | 14.68%1.68B | 19.09%1.62B | 19.38%1.61B | 19.80%1.54B | 27.03%5.46B | 23.42%1.47B |
| Gross profit | 22.17%1.12B | 24.85%1.08B | 16.77%947M | 22.79%3.62B | 19.51%1.02B | 20.42%920M | 24.42%861M | 28.73%811M | 26.73%2.94B | 29.50%856M |
| Operating expense | 16.47%580M | 11.29%552M | 14.00%513M | 21.53%1.97B | 16.15%525M | 24.19%498M | 24.31%496M | 21.62%450M | 25.76%1.62B | 23.84%452M |
| Selling and administrative expenses | 22.10%221M | 11.92%216M | 18.90%195M | 24.00%744M | 19.88%205M | 23.97%181M | 32.19%193M | 18.84%164M | 27.66%600M | 20.42%171M |
| -General and administrative expense | 22.10%221M | 11.92%216M | 18.90%195M | 24.00%744M | 19.88%205M | 23.97%181M | 32.19%193M | 18.84%164M | 27.66%600M | 20.42%171M |
| Depreciation amortization depletion | 13.25%359M | 10.89%336M | 11.19%318M | 20.08%1.23B | 13.88%320M | 24.31%317M | 19.76%303M | 23.28%286M | 24.66%1.02B | 26.01%281M |
| -Depreciation and amortization | 13.25%359M | 10.89%336M | 11.19%318M | 20.08%1.23B | 13.88%320M | 24.31%317M | 19.76%303M | 23.28%286M | 24.66%1.02B | 26.01%281M |
| Operating profit | 28.91%544M | 43.29%523M | 20.22%434M | 24.34%1.65B | 23.27%498M | 16.25%422M | 24.57%365M | 38.85%361M | 27.95%1.32B | 36.49%404M |
| Net non-operating interest income (expenses) | -5.36%-59M | -2.13%-48M | 48.15%-28M | -34.15%-220M | -48.78%-61M | -24.44%-56M | -4.44%-47M | -63.64%-54M | -74.47%-164M | -13.89%-41M |
| Non-operating interest income | 27.27%14M | 30.00%13M | 71.43%12M | 800.00%36M | 200.00%9M | --11M | --10M | 600.00%7M | 300.00%4M | --3M |
| Non-operating interest expense | -4.48%64M | 3.33%62M | 8.62%63M | 52.15%248M | 21.15%63M | 63.41%67M | 50.00%60M | 93.33%58M | 85.23%163M | 79.31%52M |
| Total other finance cost | --9M | 66.67%-1M | -866.67%-23M | 60.00%8M | 187.50%7M | ---- | -160.00%-3M | -25.00%3M | -28.57%5M | ---8M |
| Other net income (expenses) | -152.04%-247M | -363.08%-301M | 1.10%-180M | 53.63%-415M | 82.38%-74M | -180.00%-98M | 61.76%-65M | 33.09%-182M | -312.44%-895M | -611.86%-420M |
| Gain on sale of security | 403.57%85M | -5,650.00%-115M | -300.00%-30M | 163.41%26M | 214.29%40M | -286.67%-28M | 86.67%-2M | 350.00%15M | -202.50%-41M | -75.00%-35M |
| Special income (charges) | -266.67%-11M | 0.00%-4M | 62.50%-3M | -164.29%-18M | 73.68%-5M | -106.12%-3M | -300.00%-4M | -700.00%-8M | 211.11%28M | -416.67%-19M |
| -Less:Restructuring and mergern&acquisition | -200.00%-1M | -150.00%-5M | --0 | 81.48%-10M | -100.00%-6M | 102.00%1M | ---2M | -100.00%-2M | -237.50%-54M | 75.00%-3M |
| -Less:Impairment of capital assets | 500.00%12M | 50.00%9M | -70.00%3M | 7.69%28M | -50.00%11M | 100.00%2M | 500.00%6M | 400.00%10M | 271.43%26M | 266.67%22M |
| Other non-operating income (expenses) | 8.96%-61M | -208.47%-182M | 22.22%-147M | 52.31%-423M | 70.62%-109M | 32.32%-67M | 61.69%-59M | 28.68%-189M | -233.46%-887M | -724.44%-371M |
| Income before tax | -11.48%239M | -28.97%179M | 81.60%227M | 281.51%1.01B | 736.84%363M | -5.59%270M | 218.99%252M | 390.70%125M | -63.45%265M | -127.94%-57M |
| Income tax | -7.23%77M | 46.15%95M | 67.31%87M | 19.61%244M | 0.00%44M | 23.88%83M | 22.64%65M | 30.00%52M | 16.57%204M | 4.76%44M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -13.37%162M | -54.55%85M | 89.19%140M | 1,137.10%767M | 422.22%319M | -14.61%187M | 619.23%187M | 189.16%74M | -88.75%62M | -160.74%-99M |
| Net income continuous operations | -13.37%162M | -55.08%84M | 91.78%140M | 1,157.38%767M | 415.84%319M | -14.61%187M | 619.23%187M | 187.95%73M | -88.91%61M | -162.35%-101M |
| Noncontrolling interests | -308.70%-48M | 180.00%28M | 177.42%24M | 107.36%37M | 114.58%35M | 387.50%23M | 112.82%10M | 82.49%-31M | -1,423.68%-503M | -2,500.00%-240M |
| Net income attributable to the company | 28.05%210M | -68.36%56M | 9.52%115M | 29.38%731M | 102.13%285M | -27.75%164M | 71.84%177M | 11.70%105M | 10.35%565M | -7.24%141M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 28.05%210M | -68.36%56M | 9.52%115M | 29.38%731M | 102.13%285M | -27.75%164M | 71.84%177M | 11.70%105M | 10.35%565M | -7.24%141M |
| Diluted earnings per share | 27.78%9.89 | -68.14%2.66 | 9.90%5.44 | 29.28%34.48 | 102.11%13.44 | -27.66%7.74 | 71.11%8.35 | 11.49%4.95 | 10.30%26.67 | -7.51%6.65 |
| Basic earnings per share | 27.78%9.89 | -68.14%2.66 | 9.90%5.44 | 29.28%34.48 | 102.11%13.44 | -27.66%7.74 | 71.11%8.35 | 11.49%4.95 | 10.30%26.67 | -7.51%6.65 |
| Dividend per share | 0.00%1 | 0.00%1 | 0.00%1 | 0.00%4 | 0.00%1 | 0.00%1 | 0.00%1 | 0.00%1 | 0.00%4 | 0.00%1 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.